These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 799562)

  • 1. Clinical and haemodynamic study of atenolol (Tenormin) in essential hypertension.
    Jensen HA; Rasmussen K; Mosbaek N
    Clin Sci Mol Med Suppl; 1976 Dec; 3():525s-526s. PubMed ID: 799562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of atenolol in hypertension.
    Hansson L; Karlberg BE; Aberg H; Westerlund A; Henningsen NC; Jameson S
    Clin Sci Mol Med Suppl; 1976 Dec; 3():513s-515s. PubMed ID: 799559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic effect of the cardioselective beta-blocking agent tenormin and its action on the indices of systemic, intracardiac and regional hemodynamics in patients with hypertension].
    Erina EV; Charyev KhE; Oshchepkova EV
    Kardiologiia; 1983 Apr; 23(4):53-9. PubMed ID: 6865186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of hypotensive effect during betaadrenergic blockade in hypertensive patients.
    Amery A; Billiet L; Boel A; Fagard R; Reybrouck T; Willems J
    Am Heart J; 1976 May; 91(5):634-42. PubMed ID: 773142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.
    Lund-Johansen P
    Br J Clin Pharmacol; 1976 Jun; 3(3):445-51. PubMed ID: 973971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of the haemodynamic interaction between atenolol, a cardioselective beta-adrenoreceptor-blocking agent, and chlorthalidone in hypertensive patients.
    Velasco M; Guevara J; Morillo J; Ramírez A; Urbina-Quintana A; Hernandez-Pieretti O
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():363s-365s. PubMed ID: 396082
    [No Abstract]   [Full Text] [Related]  

  • 7. Haemodynamic changes during treatment of arterial hypertension with atenolol (Tenormin).
    Jensen HA; Rasmussen K; Mosbaek N
    Dan Med Bull; 1980 Jul; 27(3):153-5. PubMed ID: 7438801
    [No Abstract]   [Full Text] [Related]  

  • 8. [Haemodynamic response to antihypertensive treatment with atenolol in patients with hypertension (author's transl].
    Zilcher H; Glogar D; Uhlir H; Leisch F; Niederberger M; Steinbach K
    Wien Klin Wochenschr; 1978 Sep; 90(16):611-6. PubMed ID: 695651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hypertension with tenormin 100 (atenolol). A general practice study (author's transl)].
    Hiemstra S; Ziegler E
    MMW Munch Med Wochenschr; 1980 Dec; 122(49):1777-80. PubMed ID: 6779149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical use of atenolol (Tenormin) in arterial hypertension].
    Beloev I; Popiliev I; Tŭrnovska R; Pelov R
    Vutr Boles; 1982; 21(4):36-41. PubMed ID: 6755910
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term hypotensive effect of atenolol (ICI 66.082), a new beta-adrenergic blocking agent.
    Hansson L; Karlberg BE; Aberg H; Westerlund A; Jameson S; Henningsen NC
    Acta Med Scand; 1976; 199(4):257-61. PubMed ID: 4956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O; Rydén L
    Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atenolol (Tenormin) compared with methyldopa (Aldomet) in the treatment of hypertension.
    Okanga JB
    East Afr Med J; 1978 Sep; 55(9):447-52. PubMed ID: 361368
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind comparison of atenolol ('Tenormin') and methyldopa in the treatment of moderate hypertension in general practice: a multicentre study.
    Basker MA; Tweed JA; Barker NP
    Curr Med Res Opin; 1977; 4(9):618-26. PubMed ID: 338252
    [No Abstract]   [Full Text] [Related]  

  • 15. Controlled study of atenolol in treatment of hypertension.
    Hansson L; Aberg H; Karlberg BE; Westerlund A
    Br Med J; 1975 May; 2(5967):367-70. PubMed ID: 236810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atenolol (Tenormin) in the treatment of hypertension].
    Kawecka-Jaszcz K; Kocemba J
    Pol Tyg Lek; 1977 Dec; 32(50):1979-81. PubMed ID: 600850
    [No Abstract]   [Full Text] [Related]  

  • 17. Multicentre general practitioner assessment of 'Tenormin' and methyldopa.
    Tweed JA; Mason B; Sleigh R
    J Int Med Res; 1979; 7(4):324-7. PubMed ID: 488522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta adrenergic blocking agents to control hypertension in aviation personnel.
    Schamroth CL; Davidoff R; Schamroth JM; Myburgh DP
    Aviat Space Environ Med; 1982 Apr; 53(4):403-4. PubMed ID: 6123307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamics, biochemical and reflexive changes produced by atenolol in hypertension.
    Dreslinski GR; Messerli FH; Dunn FG; Suarez DH; Reisin E; Frohlich ED
    Circulation; 1982 Jun; 65(7):1365-8. PubMed ID: 6122514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical experience with atenolol--a new selective beta-1-blocker with few side-effects from the central nervous system.
    Henningsen NC; Mattiasson I
    Acta Med Scand; 1979; 205(1-2):61-6. PubMed ID: 367088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.